APYX vs JLL · rev $48.1M vs P/E 23, rev $23.43B
Apyx Medical Inc (APYX) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported JLL revenue for 2024-12-31 was $23.43B. Net income was $546.8M. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
APYX currently screens at market cap $179.6M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the APYX and JLL stock pages for the full models.
Not investment advice.